The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity

The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity

Summary

GBI Research has released “The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 - Growing Demand Drives Investment in Capacity”. The study, which is an offering from the company’s Chemicals Research Group, provides in-depth analysis of the global HPAPIs market with revenue forecasts up to 2015. Revenue forecasts, which include historical statistics of the market, are provided for the major regions – Europe, North America and Asia Pacific. The factors that drive and restrain the growth of the HPAPIs market are also analyzed in the report. In addition, the research provides market share analysis of the leading HPAPIs producers for major regions. The market for HPAPIs is also analyzed based on the product types and therapeutic applications at a global level. The report is built using the data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

Scope

• HPAPIs market revenues data from 2005 to 2009 and forecast for six years to 2015.
• HPAPIs in key regions – Europe, North America and Asia Pacific.
• Coverage of the product types and therapeutic applications of the global HPAPIs market.
• Drivers such as increasing demand due to the growth in better targeted drugs and restraints such as the economic recession for the global market as well as for the regional markets.
• Information on the competitive landscape with the revenue shares of the leading companies in the major regions of the world such as Sigma Aldrich, Bristol Myers Squibb, Sanofi Aventis, Carbogen Amcis and Novasep.

Reasons to buy

• Develop business strategies by understanding the trends and developments that are driving the global HPAPIs market.
• Design and develop your product development, marketing and sales strategies.
• Develop market-entry and market expansion strategies.
• Identify key companies best positioned to take advantage of the emerging market opportunities.
• Benchmark different geographies by the historic and forecasted growth of the HPAPIs market.
• Identify macro and micro-economic trends shaping and driving the global HPAPIs market.

Contents

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 GBI Report Coverage
2.2 Definitions

3 GLOBAL HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET

3.1 Introduction to High Potency Active Pharmaceutical Ingredients
  3.1.1 Category 1: Low Potency
  3.1.2 Category 2: Moderate Potency
  3.1.3 Category 4: High Potency
3.2 Global HPAPI Industry Structure
3.3 Global HPAPI Industry Challenges
  3.3.1 Requirement of Large Investments
  3.3.2 Requirement of Specialized Manufacturing Facilities
  3.3.3 Necessity of Very Specific Safety and Handling Requirements
  3.3.4 Need for Tougher Industry Standards
3.4 Global HPAPI Market Overview
3.5 Global HPAPI Market Drivers
  3.5.1 The Growth in the Global Anti-Cancer Market is the Major Force Behind the Growing Demand for HPAPIs in the World
  3.5.2 The Growth of the Targeted Therapy Approach is Driving the Demand for HPAPIs
  3.5.3 Increasing Number of Applications of HPAPIs is Contributing to Increase in the Demand for HPAPIs Worldwide
3.6 Global HPAPI Market Restraints
  3.6.1 The Global Economic Slowdown is Restricting the Growth of the HPAPI Market
  3.6.2 Conservative Approach Towards the Acceptance of New and Expensive Drugs is Seen to be a Hindrance to the Growth of the Global HPAPI Market
  3.6.3 Very High Potency May Create a Roadblock to the Growth of Some HPAPIs
3.7 Global HPAPI Market Revenue Forecasts, 2005-2015
3.8 Global HPAPI Product Types
  3.8.1 Types Based on Synthesis Route
  3.8.2 Types Based On Customer Base
3.9 Global HPAPI Market Revenue Share Analysis By Geographies
3.10 Global HPAPI Market Revenue Share Analysis by Therapeutic Applications
3.11 Global HPAPI Market Opportunity Analysis
  3.11.1 Strategic Advances in the High Potency Segment
  3.11.2 Scope for Differentiation in the HPAPI Market

4 NORTH AMERICA HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET

4.1 North America HPAPI Market Overview
4.2 North America HPAPI Market Drivers
  4.2.1 Growth in Oncology is the Major Contributing Factor for the Growth of HPAPI Demand in the Region
  4.2.2 Increasing Demand for Antibody Drug Conjugates in the Region Facilitates the Growth in HPAPI Demand
  4.2.3 The Growth of Lifestyle Diseases and Older Age Diseases is Driving the Demand for HPAPI in the Region
  4.2.4 Increasing Number of Applications is Leading to Higher HPAPI Demand in the Region
  4.2.5 Large Untapped Market Potential will Increase the HPAPI Market Growth Rate
  4.2.6 Less Competition from Other Regions Helps the HPAPI Market to Grow In North America
4.3 North America HPAPI Market Restraints
  4.3.1 Economic Slowdown is Restricting the Growth of the HPAPI Market in North America
  4.3.2 Stringent Cost-Benefit Analysis by Authorities is a Hindrance to the Growth of the HPAPI Market.
4.4 North America HPAPI Market Revenue Forecasts
4.5 North America HPAPI Market Revenue Share Analysis by Product Types
4.6 North America HPAPI Market Revenue Share Analysis By Countries
4.7 North America HPAPI Market Competitive Landscape
4.8 The US High Potency Active Pharmaceutical Ingredients Market
  4.8.1 The US HPAPI Market Overview
  4.8.2 The US HPAPI Market Revenue Forecasts
4.9 Canada High Potency Active Pharmaceutical Ingredients Market
  4.9.1 Canada HPAPI Market Overview
  4.9.2 Canada HPAPI Market Revenue Forecasts

5 EUROPE HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET

5.1 Europe HPAPI Market Overview
5.2 Europe HPAPI Market Drivers
  5.2.1 Growth in Oncology is the Major Force Behind the Growing HPAPI Demand in Europe
  5.2.2 The Increasing Incidence of Lifestyle and Older Age Diseases in Europe is Giving Rise to Demand for HPAPIs
  5.2.3 The Growth in the Market for Antibody Drug Conjugates in the Region Strongly Facilitates the Growth of the HPAPI Market
  5.2.4 Growth in the Number of HPAPI Applications is Widening the Market Demand in the Region
  5.2.5 Less Competition from Other Regions Helps the HPAPI Market Grow in Europe
5.3 Europe HPAPI Market Restraints
  5.3.1 The Downturn in the Economy Restricts the Growth of the HPAPI Market in the Region
  5.3.2 Stricter Analyses of the Cost-Benefit Ratios of Drugs by Regulatory Authorities is Becoming an Obstacle to the Growth of the HPAPI Market in the Region
  5.3.3 Very High Potency of Some HPAPI Compounds May Adversely Affect the Growth in the Region
5.4 Europe HPAPI Market Revenue Forecasts
5.5 Europe HPAPI Market Revenue Share Analysis By Product Types
5.6 Europe HPAPI Market Revenue Share Analysis By Countries
5.7 Europe HPAPI Market Competitive Landscape
5.8 The UK High Potency Active Pharmaceutical Ingredients Market
  5.8.1 The UK HPAPI Market Overview
  5.8.2 The UK HPAPI Market Revenue Forecasts
5.9 Germany High Potency Active Pharmaceutical Ingredients Market
  5.9.1 Germany HPAPI Market Overview
  5.9.2 Germany HPAPI Market Revenue Forecasts
5.10 France High Potency Active Pharmaceutical Ingredients Market
  5.10.1 France HPAPI Market Overview
  5.10.2 France HPAPI Market Revenue Forecasts
5.11 Italy High Potency Active Pharmaceutical Ingredients Market
  5.11.1 Italy HPAPI Market Overview
  5.11.2 Italy HPAPI Market Revenue Forecasts
5.12 Spain High Potency Active Pharmaceutical Ingredients Market
  5.12.1 Spain HPAPI Market Overview
  5.12.2 Spain HPAPI Market Revenue Forecasts

6 ASIA PACIFIC HIGH POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET

6.1 Asia Pacific HPAPI Market Overview
6.2 Asia Pacific HPAPI Market Drivers
  6.2.1 Strongly Growing Economies and Increasing Healthcare Standards in the Asia Pacific Region Favours the Growth of HPAPI Demand
  6.2.2 Growth in Demand of Oncology Drugs is Driving the Demand of HPAPIs in Asia Pacific
  6.2.3 Growth in the Generic Sector HPAPIs
  6.2.4 The Growing Number of Producers in the Asia Pacific Region is Helping the HPAPI Market to Grow
6.3 Asia Pacific HPAPI Market Restraints
  6.3.1 Restricted Expenditure on New Drugs in the Asia Pacific Countries Forms a Restraint to the Growth of the HPAPI Market
  6.3.2 Strict Government Policies of The Asian Countries Forms a Hurdle to the Market Growth of HPAPIs in the Asia Pacific Region
6.4 Asia Pacific HPAPI Market Revenue Forecasts
6.5 Asia Pacific HPAPI Market Revenue Share Analysis by Product Types
6.6 Asia Pacific HPAPI Market Revenue Share Analysis by Country
6.7 Asia Pacific HPAPI Market Competitive Landscape
6.8 Japan High Potency Active Pharmaceutical Ingredients Market
  6.8.1 Japan HPAPI Market Overview
  6.8.2 Japan HPAPI Market Revenue Forecasts
6.9 India High Potency Active Pharmaceutical Ingredients Market
  6.9.1 India HPAPI Market Overview
  6.9.2 India HPAPI Market Revenue Forecasts
6.10 China High Potency Active Pharmaceutical Ingredients Market
  6.10.1 China HPAPI Market Overview
  6.10.2 China HPAPI Market Revenue Forecasts

7 APPENDIX

7.1 Methodology
  7.1.1 Coverage
  7.1.2 Secondary Research
  7.1.3 Primary Research
  7.1.4 Expert Panel Validation
7.2 Units Of Measure
7.3 Contact Us
7.4 About GBI Research
7.5 Disclaimer

1.1 LIST OF TABLES


Table 1: API Potency Classification Scheme
Table 2: Global HPAPI Market, Revenue Forecasts, 2005-2015
Table 3: Global HPAPI Market, Revenue Shares By Types Based On Synthesis Route, 2009
Table 4: Global HPAPI Market, Revenue Share Analysis By Types Based On Customer Base, 2009
Table 5: Global HPAPI Revenue Share Analysis By Geographies, 2009
Table 6: Global HPAPI Market, Revenue Share Analysis By Therapeutic Applications
Table 7: North America HPAPI Market, Revenue Forecasts, 2005-2015
Table 8: North America HPAPI Market, Revenue Share Analysis By Product Types, 2009
Table 9: North America HPAPI Market, Revenue Share Analysis By Countries, 2009
Table 10: North America HPAPI Market, Revenue Share Analysis By Companies, 2009
Table 11: The US HPAPI Market, Revenue Forecasts, 2005-2015
Table 12: Canada HPAPI Market, Revenue Forecasts, 2005-2015
Table 13: Europe HPAPI Market, Revenue Forecasts, 2005-2015
Table 14: Europe HPAPI Market, Revenue Share Analysis By Product Types, 2009
Table 15: Europe HPAPI Market, Revenue Share Analysis By Countries
Table 16: Europe HPAPI Market, Revenue Share Analysis By Companies, 2009
Table 17: The UK HPAPI Market Revenue Forecasts, 2005-2015
Table 18: Germany HPAPI Market Revenue Forecasts, 2005-2015
Table 19: France HPAPI Market, Revenue Forecasts, 2005-2015
Table 20: Italy HPAPI Market Revenue Forecasts, 2005-2015
Table 21: Spain HPAPI Market Revenue Forecasts, 2005-2015
Table 22: Asia Pacific HPAPI Market Revenue Forecasts, 2005-2015
Table 23: Asia Pacific HPAPI Market, Revenue Share Analysis By Product Types, 2009
Table 24: Asia Pacific HPAPI Market, Revenue Share Analysis By Country, 2009
Table 25: Japan HPAPI Market, Revenue Forecasts, 2005-2015
Table 26: India HPAPI Market, Revenue Forecasts, 2005-2015
Table 27: China HPAPI Market, Revenue Forecasts, 2005-2015

1.2 LIST OF FIGURES


Figure 1: Global HPAPI Market, Value Chain, 2009
Figure 2: Global HPAPI Market, Revenue Forecasts, 2005-2015
Figure 3: Global HPAPI Market, Revenue Shares By Types Based On Synthesis Route, 2009
Figure 4: Global HPAPI Market, Revenue Share Analysis By Types Based On Customer Base, 2009
Figure 5: Global HPAPI, Product Types, 2009
Figure 6: Global HPAPI Market, Revenue Share Analysis By Geographies, 2009
Figure 7: Global HPAPI Market, Revenue Share Analysis By Therapeutic Applications
Figure 8: North America HPAPI Market, Revenue Forecasts, 2005-2015
Figure 9: North America HPAPI Market, Revenue Share Analysis By Product Types, 2009
Figure 10: North America HPAPI Market, Revenue Share Analysis By Countries, 2009
Figure 11: North America HPAPI Market, Revenue Share Analysis By Companies, 2009
Figure 12: The US HPAPI Market, Revenue Forecasts, 2005-2015
Figure 13: Canada HPAPI Market, Revenue Forecasts, 2005-2015
Figure 14: Europe HPAPI Market, Revenue Forecasts, 2005-2015
Figure 15: Europe HPAPI Market, Revenue Share Analysis By Product Types, 2009
Figure 16: Europe HPAPI Market, Revenue Share Analysis By Countries, 2009
Figure 17: Europe HPAPI Market, Revenue Share Analysis By Companies, 2009
Figure 18: The UK HPAPI Revenue Forecasts, 2005-2015
Figure 19: Germany HPAPI Market Revenue Forecasts, 2005-2015
Figure 20: France HPAPI Market, Revenue Forecasts, 2005-2015
Figure 21: Italy HPAPI Market Revenue Forecasts, 2005-2015
Figure 22: Spain HPAPI Market Revenue Forecasts, 2005-2015
Figure 23: Asia Pacific HPAPI Market Revenue Forecasts, 2005-2015
Figure 24: Asia Pacific HPAPI Market, Revenue Share Analysis By Product Types, 2009
Figure 25: Asia Pacific HPAPI Market, Revenue Share Analysis By Country, 2009
Figure 26: Japan HPAPI Market, Revenue Forecasts, 2005-2015
Figure 27: India HPAPI Market, Revenue Forecasts, 2005-2015
Figure 28: China HPAPI Market, Revenue Forecasts, 2005-2015
Figure 29: GBI Research Methodology, 2010 Skip to top